MorphoSys AG Sees Significant Decline in Short Interest
Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MorphoSys |
MorphoSys AG was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 52,000 shares, a drop of 65.0 percent from the January 15th total of 148,700 shares. Based on an average daily trading volume, of 174,200 shares, the
Read at thelincolnianonline.com
 |
MorphoSys Fundamental Analysis
We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
MorphoSys is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
MorphoSys AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.
Peers
MorphoSys Related Equities
| NVCT | Nuvectis Pharma | 5.25 | ||||
| IMCR | Immunocore Holdings | 1.62 | ||||
| PMVP | Pmv Pharmaceuticals | 1.34 | ||||
| IPSC | Century Therapeutics | 0.97 | ||||
| GOSS | Gossamer Bio | 0.56 | ||||
| ELVN | Enliven Therapeutics | 0.49 | ||||
| KRON | Kronos Bio | 0 | ||||
| RLYB | Rallybio Corp | 0 | ||||
| CGEM | Cullinan Oncology | 0.16 | ||||
| PCVX | Vaxcyte | 0.16 | ||||
| GBIO | Generation Bio | 0.93 | ||||
| CCCC | C4 Therapeutics | 1.10 | ||||
| GLUE | Monte Rosa | 1.14 | ||||
| EWTX | Edgewise Therapeutics | 1.33 | ||||
| MRSN | Mersana Therapeutics | 1.40 | ||||
| MLYS | Mineralys Therapeutics, | 1.68 | ||||
| REPL | Replimune | 1.78 | ||||
| VTYX | Ventyx Biosciences | 1.79 | ||||
| LYRA | Lyra Therapeutics | 1.90 | ||||
| ACLX | Arcellx | 2.12 | ||||
| IMRX | Immuneering Corp | 2.22 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |